Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones
- PMID: 17720234
- PMCID: PMC2831219
- DOI: 10.1016/j.ygyno.2007.07.061
Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones
Abstract
Objectives: Data suggest that post-menopausal women with larger ovaries are at increased risk for endometrial carcinoma; however, analyses comparing ovarian volume to serum hormone levels are limited. Accordingly, we assessed ovarian volumes in relation to serum sex hormone levels among post-menopausal women with endometrial carcinoma who participated in a multi-center case-control study.
Methods: Data for established risk and protective factors for endometrial carcinoma were collected via in-person interviews. Ovarian volumes were estimated from pathology reports. Associations between exposures and age-adjusted ovarian volumes were analyzed for 175 cases with available data. For a subset of 135 cases, we analyzed relationships between ovarian volume, adjusted for age and body mass index (BMI), and serum hormone levels by analysis of variance.
Results: Ovarian volume declined progressively from 1.83 cm3 among women ages 55-59 years to 1.23 cm3 among women age 70 years or older (p-trend=0.02). Larger ovarian volume was associated with early menarche (p-trend=0.03), having given birth (p=0.01), and weakly with elevated BMI (p-trend=0.06). After adjustment, increased ovarian volume was associated with higher estradiol (p-trend=0.007); albumin-bound estradiol (p-trend=0.01); and free estradiol (p-trend=0.006) levels; androstenedione, estrone and estrone sulfate showed similar, though non-significant associations.
Conclusions: Among women with endometrial carcinoma, larger ovaries were associated with higher serum levels of estrogens. Further studies examining the role of the ovaries in post-menopausal hormonal carcinogenesis are warranted.
Similar articles
-
Case-control study of endogenous steroid hormones and endometrial cancer.J Natl Cancer Inst. 1996 Aug 21;88(16):1127-35. doi: 10.1093/jnci/88.16.1127. J Natl Cancer Inst. 1996. PMID: 8757192
-
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).Endocr Relat Cancer. 2008 Jun;15(2):485-97. doi: 10.1677/ERC-07-0064. Endocr Relat Cancer. 2008. PMID: 18509001 Free PMC article.
-
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.Int J Cancer. 2004 Jan 20;108(3):425-32. doi: 10.1002/ijc.11529. Int J Cancer. 2004. PMID: 14648710
-
Case-control study of endogenous sex steroid hormones and risk of endometrial cancer.Cancer Causes Control. 2020 Feb;31(2):161-171. doi: 10.1007/s10552-019-01260-5. Epub 2019 Dec 21. Cancer Causes Control. 2020. PMID: 31865473
-
Plasma steroid transport in subjects with tumors of hormonal target organs: a review.Tumori. 1992 Jun 30;78(3):155-8. doi: 10.1177/030089169207800302. Tumori. 1992. PMID: 1440937 Review.
Cited by
-
Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis.J Natl Cancer Inst. 2014 Sep 13;106(10):dju262. doi: 10.1093/jnci/dju262. Print 2014 Oct. J Natl Cancer Inst. 2014. PMID: 25217774 Free PMC article.
-
Expression of OATP family members in hormone-related cancers: potential markers of progression.PLoS One. 2011;6(5):e20372. doi: 10.1371/journal.pone.0020372. Epub 2011 May 19. PLoS One. 2011. PMID: 21625523 Free PMC article.
-
Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.Am J Obstet Gynecol. 2022 Jul;227(1):61.e1-61.e18. doi: 10.1016/j.ajog.2022.02.022. Epub 2022 Feb 22. Am J Obstet Gynecol. 2022. PMID: 35216968 Free PMC article.
-
Ovarian volume assessment in relation to histologic findings and sex hormone levels in women with postmenopausal bleeding and thickened endometrium.Ann Saudi Med. 2012 Nov-Dec;32(6):588-92. doi: 10.5144/0256-4947.2012.588. Ann Saudi Med. 2012. PMID: 23396021 Free PMC article.
-
A model of estrogen-related gene expression reveals non-linear effects in transcriptional response to tamoxifen.BMC Syst Biol. 2012 Nov 8;6:138. doi: 10.1186/1752-0509-6-138. BMC Syst Biol. 2012. PMID: 23134774 Free PMC article.
References
-
- Cooke LS, Weiss NS. Endometrial Cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer Epidemiology and Prevention. New York: Oxford University Press; 2006.
-
- Calle EE, Thun MJ. Obesity and cancer. Oncogene. 2004;23:6365–78. - PubMed
-
- Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11:153–43. - PubMed
-
- Lukanova A, Lundin E, Zeleniuch-Jacquotte A, et al. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol. 2004;150:161–71. - PubMed
-
- Potischman N, Hoover RN, Brinton LA, et al. Case-control study of endogenous steroid hormones and endometrial cancer. N Natl Cancer Inst. 1996;88:1127–35. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources